Search found 5 matches
- Sat Jul 29, 2006 8:11 am
- Forum: Copaxone
- Topic: Copaxone Site Pain
- Replies: 6
- Views: 5003
I sometimes get a sting or itching/redness in one particular spot, but not always. I suggest a depth adjustment (with or without the autoject). Deeper is sometimes better. As you make adjustments, you'll probably find a depth that works best in each area you inject. Take notes (Shared Solutions can ...
- Wed Jul 12, 2006 5:21 am
- Forum: Tysabri (Antegren, Natalizumab)
- Topic: Appointment for First Infusion?
- Replies: 35
- Views: 12879
Exactly my point...know the risk. Some of the recent news, and its associated hype, has neglected to provide fair balance about risk. My doctor talked to me about antigren when it was in clinical trials, but suggested we wait until we know more about the risks. That's my suggestion to anyone conside...
- Tue Jul 11, 2006 8:51 pm
- Forum: Tysabri (Antegren, Natalizumab)
- Topic: Appointment for First Infusion?
- Replies: 35
- Views: 12879
With all that's been written, there's still too much unknown
Before you decide, read these articles at the New England Journal of Medicine (you can get a free subscription online) 1) Toxic Leukoencephalopathy http://content.nejm.org/cgi/content/short/345/6/425 2) Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab http://content.n...
- Tue Jul 11, 2006 8:07 pm
- Forum: Copaxone
- Topic: Copaxone Site Pain
- Replies: 6
- Views: 5003
I think you should talk to Shared Solutions for an official response, but... Yes, definitely! They make it adjustable for a reason. I think injecting deeper is better in areas where you've got a little extra chiach (except if you hit a muscle). It takes some playing-with to find the right settings f...
- Tue Jul 11, 2006 7:47 pm
- Forum: Copaxone
- Topic: Higher dose Copaxone
- Replies: 3
- Views: 3515
small steps often lead to large bounds
Harry's comments are a bit cynical, but MS can make us prolific cynics. When you evaluate this or any study, remember that the research community builds upon the results of previous studies. While the quoted study may help sell some more Copaxone in the short term, it may also be the first step in d...